TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TREATMENT WITH AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF TTR (ISIS-TTR RX)

被引：0
|
作者：
Benson, M. D. [1 ]
Ackermann, E. J. [2 ]
Monia, B. [2 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] ISIS Pharmaceut Inc, Carlsbad, CA USA
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [41] DEVELOPMENT OF ALN-TTR, AN RNAI THERAPEUTIC FOR THE TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS
    Alvarez, Rene
    Borland, Todd
    Chen, Qingmin
    Milstein, Stuart
    Nguyen, Tuyen
    Hinkle, Greg
    Kuchimanchi, Satya
    Costigan, Jason
    Ristoiu, Violeta
    Wang, Gang
    Cole, Geoffrey
    Dorkin, Robert
    Akinc, Akin
    Nechev, Lubomir
    Kosovrasti, Verbena
    Tchangov, Lubomir S.
    Tracy, Mark
    Gamba-Vitalo, Christina
    Jeffs, Lloyd B.
    MacLachlan, Ian
    Lutwyche, Peter
    Ribiero, Tania
    Saraiva, Maria Joao
    Sah, Dinah W.
    HEPATOLOGY, 2009, 50 (06) : 5A - 6A
  • [42] AG10 Stabilizes Pathogenic TTR Variants With High Potency - Potential for an Effective Treatment for TTR Cardiomyopathy
    Graef, Isabella A.
    Lee, Yi
    Miller, Mark
    Alhamadsheh, Mamoun
    Witteles, Ron
    Liedtke, Michaela
    Sinha, Uma
    Zamboni, Robert
    Kumar, Neil
    Fox, Jonathan
    Judge, Daniel
    CIRCULATION, 2017, 136
  • [43] EXPLORATORY CARDIAC MEASURES IN PATIENTS WITH SEVERE HEREDITARY TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TREATED WITH INOTERSEN IN THE PHASE 3 NEURO-TTR STUDY
    Mussinelli, R.
    Whelan, C.
    Drachman, B.
    Heitner, S.
    Maurer, M.
    Damy, T.
    Hughes, S.
    Kwoh, J.
    Narayana, A.
    Benson, M.
    Perlini, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G82 - G83
  • [44] Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy (TTR-FAP)
    Conceicao, I.
    Gonzalez Duarte, A.
    Obici, L.
    Schmidt, H.
    Simoneau, D.
    Ong, M. -L.
    Amass, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 167 - 167
  • [45] Identification of 3 new variants of the transthyretin (TTR) and study of haplotypes in familial amyloid polyneuropathy (FAP)
    Bordeneuve, VP
    Bicetre, LEK
    Lalu, T
    Misrahi, M
    Said, G
    NEUROLOGY, 1997, 48 (03) : 6089 - 6089
  • [46] Hereditary transthyretin amyloidosis with cardiomyopathy: which are the TTR variants associated with early- onset involvement?
    Algalarrondo, Vincent
    Robo, Solene
    Veil, Simone
    Echaniz-Laguna, Andoni
    Monfort, Astrid
    Chequer, Renata
    Inamo, Jocelyn
    Rouzet, Francois
    Slama, Michel S.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S24 - S25
  • [47] Evaluation of Isis Apo(a)Rx, an Antisense Inhibitor to Apolipoprotein(a), in Healthy Volunteers
    Viney, Nick
    Graham, Mark
    Crooke, Rosanne
    Hughes, Steve
    Singleton, Walter
    CIRCULATION, 2013, 128 (22)
  • [48] TRANSTHYRETIN (TTR) DNA ANALYSIS: EXPERIENCE OF THE INDIANA UNIVERSITY SCHOOL OF MEDICINE AMYLOID RESEARCH CENTER
    Benson, M. D.
    Hardwick, J.
    Michael, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 104 - 104
  • [49] ALN-TTR, an RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis
    Alvarez, R.
    Borland, T.
    Chen, Q.
    Milstein, S.
    Nguyen, T.
    Hinkle, G.
    Kuchimanchi, S.
    Costigan, J.
    Ristoiu, V.
    Wang, G.
    Cole, G.
    Dorkin, R.
    Akinc, A.
    Nechev, L.
    Kosovrasti, V.
    Tchangov, L.
    Tracy, M.
    Jeffs, L.
    MacLachlan, I.
    Lutwyche, P.
    Martins, D.
    Costelha, S.
    Saraiva, M. J.
    Sah, D. W. Y.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 51 - 52
  • [50] Gender-dependent amyloid deposition in aging male mice transgenic for human transthyretin (TTR).
    Teng, M
    Yin, J
    Vidal, R
    Ghiso, J
    Gallo, G
    Buxbaum, J
    FASEB JOURNAL, 1998, 12 (04): : A325 - A325
12345